Zinellu Angelo, Fois Alessandro Giuseppe, Sotgia Salvatore, Zinellu Elisabetta, Bifulco Fabiana, Pintus Gianfranco, Mangoni Arduino A, Carru Ciriaco, Pirina Pietro
Department of Biomedical Sciences, University of Sassari, Sassari, Italy.
Department of Clinical and Experimental Medicine, University of Sassari, Sassari, Italy.
Eur J Clin Invest. 2016 Feb;46(2):181-8. doi: 10.1111/eci.12582. Epub 2016 Jan 8.
Chronic obstructive pulmonary disease (COPD) and asthma are both characterized by heterogeneous chronic airway inflammation and obstruction as well as oxidative stress (OS). However, it is unknown whether OS occurs in early disease and how to best assess its presence. Plasma OS markers (TBARS, PSH, taurine, GSH, ergothioneine and paraoxonase 1 activity) and lung function tests were measured in patients with mild stable asthma (n = 24) and mild stable COPD (n = 29) and in age- and sex-matched controls. Forced expiratory volume in 1 s (FEV1 ) was associated with age both in patients and control groups. By contrast, FEV1 was positively correlated with PSH only in COPD (ρ = 0·49, P = 0·007). In multiple logistic regression analysis, lower PSH was the only OS marker independently associated with increased odds of both asthma (OR = 0·32, 95% CI 0·13-0·78, P = 0·01) and COPD (OR = 0·50, 95% CI 0·26-0·95, P = 0·03). These findings suggest that proteins -SH are a sensitive OS marker in early COPD and asthma.
慢性阻塞性肺疾病(COPD)和哮喘均以慢性气道炎症和阻塞的异质性以及氧化应激(OS)为特征。然而,尚不清楚氧化应激是否在疾病早期出现以及如何最好地评估其存在情况。对轻度稳定哮喘患者(n = 24)、轻度稳定慢性阻塞性肺疾病患者(n = 29)以及年龄和性别匹配的对照组进行了血浆氧化应激标志物(硫代巴比妥酸反应物、巯基、牛磺酸、谷胱甘肽、麦角硫因和对氧磷酶1活性)和肺功能测试。在患者组和对照组中,第1秒用力呼气量(FEV1)均与年龄相关。相比之下,FEV1仅在慢性阻塞性肺疾病中与巯基呈正相关(ρ = 0·49,P = 0·007)。在多因素逻辑回归分析中,较低的巯基是唯一与哮喘(比值比= 0·32,95%置信区间0·13 - 0·78,P = 0·01)和慢性阻塞性肺疾病(比值比= 0·50,95%置信区间0·26 - 0·95,P = 0·03)发病几率增加独立相关的氧化应激标志物。这些发现表明,蛋白质巯基是早期慢性阻塞性肺疾病和哮喘中一种敏感的氧化应激标志物。